New insights into hidradenitis suppurativa diagnosis via salivary infrared biosignatures: A pilot study

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease which can lead to a prolonged physical disability. HS diagnosis is exclusively clinical with the absence of biomarkers. Our study aims at assessing the HS-diagnostic potential of infrared spectroscopy from saliva, as a biofluid reflecting the body's pathophysiological state. Infrared spectra from 127 patients (57 HS and 70 non-HS) were processed by multivariate methods: principal component analysis coupled with Kruskal-Wallis or Mann-Whitney tests to identify discriminant spectral wavenumbers and linear discriminant analysis to evaluate the performances of HS-diagnostic approach. Infrared features, mainly in the 1300 cm(-1)-1600 cm(-1) region, were identified as discriminant for HS and prediction models revealed diagnostic performances of about 80%. Tobacco and obesity, two main HS risk factors, do not seem to alter the infrared diagnosis. This pilot study shows the potential of salivary liquid biopsy associated to vibrational spectroscopy to develop a personalized medical approach for HS patients' management.

Automated summary

The study demonstrates the potential of using infrared spectroscopy on saliva to diagnose hidradenitis suppurativa with an accuracy of about 80%. Risk factors such as obesity and smoking do not appear to affect the accuracy of infrared diagnosis for HS. This research highlights the possibility of developing a personalized medical approach for managing HS patients using salivary liquid biopsy combined with vibrational spectroscopy.